Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Bloomingdale's Names New CEO
Bloomingdale's named Olivier Bron its new chief executive, replacing Tony Spring, who will become CEO of Macy's.
Load More